Here are five recent oncology-related studies published by Becker's since July 12, starting with the most recent:
1. A study from Austria published Aug. 10 and led by MedUni Vienna showed a partial or complete regression of brain metastasis in breast cancer patients after treatment with trastuzumab deruxtecan (T-Dxd).
2. Oncologists’ average income rose about 2 percent, to $411,000 in 2022, according to Medscape's "Oncologist Wealth & Debt Report," published Aug. 5.
3. A gene that is responsible for the deadliest type of brain tumor is also responsible for two forms of rhabdomyosarcoma, a childhood cancer affecting soft tissue, researchers at Charlottesville, Va.-based UVA Health found July 27.
4. Three studies published in JAMA Internal Medicine found that cancer centers often deviate from testing guidelines, which can lead to unnecessary screenings and complications in older adults, The New York Times reported July 17.
5. Glyphosate, a cancer-causing herbicide, was found in 80 percent of urine samples from kids and adults in the U.S., the CDC's National Health and Nutrition Examination Survey found July 12.